In the plasma, IL-11 in the NSCLC patients was significantly greater than that of the normal volunteers (mean ± SD: 49.71 ± 16.90 pg/mL vs. 27.67 ± 14.06, p < 0.0001; Figure 1A). This evidence concerns the gene IL11 and non-small cell lung carcinoma.